Diego Marcelo Conti ^1* Vibeke Backer ² Wytske Fokkens ³ Philippe Gevaert ⁴ Anju Peters ⁵ Glenis Kathleen Scadding ⁶ Ian Pavord ⁷ Susanne Lau ⁸ Michael Wechsler ⁹ Xander Bertels ¹ Georgia Liva ¹⁰ Maria Doulaptsi ¹⁰ Emmanuel Prokopakis ¹⁰ Peter Hellings ¹

• ¹ EUFOREA, Brussels, Belgium
• ² Department of Otorhinolaryngology, Head & Neck Surgery, and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark., Copenhagen, Denmark
• ³ Department of Otorhinolarynogology and Head/Neck surgery, Amsterdam University Medical Centres, location AMC, University of Amsterdam, Amsterdam, The Netherlands., Amsterdam, Netherlands
• ⁴ Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Belgium., Gent, Belgium
• ⁵ Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Chicago, United States
• ⁶ Department of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom., London, United Kingdom
• ⁷ Respiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Oxford, United Kingdom
• ⁸ Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Berlin, Germany
• ⁹ Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA., Durham, United States
• ¹⁰ Department of Otorhinolaryngology, University of Crete, School of Medicine, Heraklion, Greece., Heraklion, Greece

The European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized the first European Biologic Training Course (EBTC) in Brussels on 1st March 2024. The aim of this hybrid EBTC including both face-to-face and web-based participation was to address the educational needs of physicians dealing with asthma and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) on the clinically relevant aspects of diagnosing and treatment with biologics. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic respiratory diseases through the implementation of optimal patient care via educational, research, and advocacy activities. The inclusive and multidisciplinary approach of EUFOREA was reflected in faculty coming from the paediatric, allergology, pulmonology, and Ear, Nose and Throat (ENT) speciality and from different continents, with more than 250 participants from over 30 countries in the first EBTC. The current report provides a comprehensive overview of key statements made by the faculty of the EBTC 2024, especially focusing on patient selection for a biologic drug, the communication with patients, the onset of biological treatment and the follow-up in routine clinical practice.